More recently, bioinformatics analysis has shown that CRYL1 is a shared susceptibility gene between late-stage hepatocellular carcinoma and high HBA1c, and that the amount of CRYL1 is inversely related to tumor stage [47]. The gene discussed is CRYL1; the disease is hepatocellular carcinoma.